Skip to main content

Diclofenac sodium

ADVERTISEMENT
Identification
Molecular formula
C14H10Cl2NO2.Na
CAS number
15307-79-6
IUPAC name
(2R,3R,4S,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
State
State

At room temperature, Diclofenac sodium typically exists in a solid state. It is commonly found as a crystalline powder or crystals.

Melting point (Celsius)
283.00
Melting point (Kelvin)
556.15
Boiling point (Celsius)
312.80
Boiling point (Kelvin)
586.00
General information
Molecular weight
318.13g/mol
Molar mass
296.1480g/mol
Density
1.5120g/cm3
Appearence

Crystals or crystalline powder that can appear white to off-white. It may also appear faintly yellowish. It often appears as distinct crystals or powder with a fine texture.

Comment on solubility

Solubility of (2R,3R,4S,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

The solubility of the compound with the chemical formula C14H10Cl2NO2.Na is quite intricate, reflecting its unique structure and the presence of various functional groups.

Key Factors Influencing Solubility:

  • Polar and Non-Polar Interactions: The compound contains polar functional groups such as hydroxyl (-OH) and amine (-NH) which typically enhance solubility in polar solvents like water.
  • Sodium Ion (Na+): The addition of sodium can improve solubility in aqueous environments, leading to increased interaction with water molecules.
  • Halogen Atoms: The presence of chlorine atoms may influence solubility due to their electronegativity, modifying the compound's overall hydrophilicity.

In general, the solubility of this compound can be characterized as:

  1. Moderately soluble in water: Thanks to its hydroxymethyl and diol groups that can form hydrogen bonds.
  2. Better solubility in organic solvents: Such as dimethyl sulfoxide (DMSO) or methanol due to hydrophobic interactions associated with the aromatic rings.

Overall: The solubility of (2R,3R,4S,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol is a balance of its polar functional groups and hydrophobic aromatic components, making it an interesting compound to study in various solvent systems.

Interesting facts

Interesting Facts about (2R,3R,4S,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

This fascinating compound, often referred to as a complex synthetic molecule, belongs to a class of compounds closely related to benzimidazoles, which are known for their biological activity. Here are some noteworthy points regarding this specific compound:

  • Structural Diversity: The compound has multiple stereocenters (four in total), resulting in a rich array of possible isomers. This structural complexity is essential in medicinal chemistry as it allows for varied interactions with biological targets.
  • Pharmacological Relevance: The incorporation of a benzimidazole moiety is significant. Compounds in this category have been recognized for their effectiveness as anti-parasitic and anti-cancer agents, highlighting the importance of their study in drug development.
  • Environmental Considerations: The presence of chlorinated substituents in the structure raises interesting points regarding the compound's potential environmental impact. Chlorinated compounds can exhibit different reactivity and stability patterns, which are critical in assessing their environmental footprint.
  • Uniqueness: The specific stereochemistry denoted by the (2R, 3R, 4S, 5R) notations is pivotal, as chiral centers contribute significantly to the compound's interactions in biological systems, influencing efficacy and safety in therapeutic contexts.
  • Applications: Research is ongoing into the potential applications of this compound. Its unique structure may provide insights into new therapeutic pathways and enhance understanding of drug-receptor interactions.

In conclusion, (2R,3R,4S,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol is not just a compound; it's a bridge between chemistry and biology, opening doors to innovations in pharmaceuticals and environmental sciences. As the study of such molecules continues to evolve, so too will our understanding of their significance in both scientific and practical applications.

Synonyms
53-85-0
5,6-Dichlorobenzimidazole riboside
DRB
Dichlororibofuranosylbenzimidazole
NSC 401575
5,6-Dichlorobenzimidazole 1-beta-D-ribofuranoside
5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole
BRN 0039123
5,6-Dichloro-1-Beta-D-Ribofuranosyl-1h-Benzimidazole
MFCD00036785
CHEMBL375530
8153319T3Q
1H-BENZIMIDAZOLE, 5,6-DICHLORO-1-BETA-D-RIBOFURANOSYL-
DTXSID50967472
4-23-00-01097 (Beilstein Handbook Reference)
Benzimidazole, 5,6-dichloro-1-beta-D-ribofuranosyl-
NSC-401575
(2R,3R,4S,5R)-2-(5,6-Dichloro-1H-benzo[d]imidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
5,6-dichlororibofuranosylbenzimidazole
5,6-Dichlorobenzimidazole-1-b-D-ribofuranoside
5,6-Dichloro-1-.beta.-D-ribofuranosylbenzimidazole
Benzimidazole, 5,6-dichloro-1-.beta.-D-ribofuranosyl-
BENZIMIDAZOLE, 5,6-DICHLORO-1-D-RIBOFURANOSYL-
Dichlorobenzimidazole Riboside
1-.BETA.-D-RIBOFURANOSYL-5,6-DICHLOROBENZIMIDAZOLE
5,6-DICHLORO-1-(.BETA.-D-RIBOFURANOSYL)BENZIMIDAZOLE
5,6-DICHLOROBENZIMIDAZOLE 1-.BETA.-D-RIBOFURANOSIDE
5,6-DICHLORO-1-.BETA.-D-RIBOFURANOSYL-1H-BENZIMIDAZOLE
(2R,3R,4S,5R)-2-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
DRB;
5,6-Dichloropurine-1-b-D-ribofuanosyl-H-benzimidazole
Riboside, Dichlorobenzimidazole
NSC401575
2rkp
5,6-Dichloro-1-beta-ribofuranosylbenzimidazole
(2R,3R,4S,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
RFZ
5,6-Dichloro-1-beta-D-ribofuranosyl-1-H-benzimidazol
5,6-Dichloropurine-1-beta-D-ribofuanosyl-H-benzimidazole
1-beta-D-ribofuranosyl-5,6-dichlorobenzimidazole
3my1
3my5
5,6-dichloro-1-(beta-d-ribofuranosyl)benzimidazole
5,6 Dichloro 1 beta ribofuranosylbenzimidazole
SCHEMBL62273
MLS002153177
DICHLORORIBOBENZIMIDAZOLE
5,6 Dichloro 1 beta D ribofuranosyl 1 H benzimidazol
GTPL5178
BDBM11324
3h30
XHSQDZXAVJRBMX-DDHJBXDOSA-N
DTXCID701477126
HMS2235L12
UNII-8153319T3Q
AKOS027250792
5,6-dichloro-ribofuranosylbenzimidazole
DB08473
DBR;5,6-Dichlorobenzimidazole riboside
ND06701
SDCCGSBI-0654288.P001
SMP1_000095
5,6-Dichlorobenzimidazole riboside(DBR)?
HY-14392
SMR001230669
CS-0003334
NS00069515
T71029
Q4639543
5,6-Dichloropurine-1-?-D-ribofuanosyl-H-benzimidazole
1H-Benzimidazole, 5,6-dichloro-1-beta-D-ribofuranosyl-(9CI)
5 pound not6-Dichloropurine-1-|A-D-ribofuanosyl-H-benzimidazole
5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole - CAS 53-85-0